Stock data
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN) reported revenue of US$1.98M and net income of -US$9.63M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.98M | — | -US$10.37M | -US$9.63M | — |
| 2024 | US$11.20M | — | -US$1.16M | US$0.01M | — |
| 2023 | -US$2.85M | — | -US$17.93M | -US$16.35M | — |
| 2022 | US$0.50M | — | -US$12.12M | -US$10.76M | — |
| 2021 | US$16.14M | — | US$3.15M | -US$0.63M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.19M | -US$2.62M | — |
| 2026-03-31 | US$0.12M | -US$3.67M | — |
| 2025-12-31 | US$1.15M | -US$2.37M | — |
| 2025-09-30 | US$0.11M | -US$3.19M | — |
| 2025-06-30 | US$0.62M | -US$2.21M | — |
| 2025-03-31 | US$0.09M | -US$1.86M | — |
| 2024-12-31 | — | US$1.78M | — |
| 2024-09-30 | — | -US$2.22M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.